Furthermore, the biochemical assays, western blotting as well as immunofluorescence analysis were comprehensively performed to clarify the possible effects of HAL and HAR on some underlying mechanisms involved in AD progressions. The gene discussed is LYVE1; the disease is Alzheimer disease.